Drugs Made In America Acquisition Corp
DMAAU10.490USD
+0.010+0.10%
Market hours （ET）Quotes delayed by 15 min
0.00Market Cap
--P/E TTM
More Details of Drugs Made In America Acquisition Corp Company
Drugs Made In America Acquisition Corp. is a blank check company. The Company is incorporated as an exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. Its efforts to identify a prospective target business will not be limited to a particular industry or geographic region although it intends to focus its search for business combination targets in the pharmaceutical industry.
Drugs Made In America Acquisition Corp Info
Ticker SymbolDMAAU
Company nameDrugs Made In America Acquisition Corp
IPO dateJan 28, 2025
CEOMs. Lynn Stockwell
Number of employees- -
Security typeUnit
Fiscal year-end- -
Address1 East Broward Boulevard
CityFT LAUDERDALE
Stock exchangeNASDAQ Global Market Consolidated
CountryUnited States of America
Postal code33301
Phone19548703099
Website
Ticker SymbolDMAAU
IPO dateJan 28, 2025
CEOMs. Lynn Stockwell
Company Executives of Drugs Made In America Acquisition Corp
Name
Name/Position
Position
Shareholding
Change
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director Nominee
Independent Director Nominee
--
--
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Mr. Glenn C. Worman
Mr. Glenn C. Worman
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Catherine Do
Dr. Catherine Do
Independent Director Nominee
Independent Director Nominee
--
--
Name
Name/Position
Position
Shareholding
Change
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director Nominee
Independent Director Nominee
--
--
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Mr. Glenn C. Worman
Mr. Glenn C. Worman
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Catherine Do
Dr. Catherine Do
Independent Director Nominee
Independent Director Nominee
--
--
Revenue Breakdown
No Data
No Data
By Business
By Region
No Data
Shareholding Stats
Updated: Sat, May 17
Updated: Sat, May 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Drugs Made In America Acquisition LLC
17.88%
RiverNorth Capital Management LLC
1.79%
Context Capital Management LLC
1.07%
Wolverine Asset Management, LLC
0.55%
Bulldog Investors, LLP
0.24%
Other
78.46%
Shareholders
Shareholders
Proportion
Drugs Made In America Acquisition LLC
17.88%
RiverNorth Capital Management LLC
1.79%
Context Capital Management LLC
1.07%
Wolverine Asset Management, LLC
0.55%
Bulldog Investors, LLP
0.24%
Other
78.46%
Shareholder Types
Shareholders
Proportion
Corporation
17.88%
Investment Advisor/Hedge Fund
2.25%
Hedge Fund
1.68%
Research Firm
0.20%
Investment Advisor
0.08%
Other
77.91%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
19
986.13K
4.21%
-2.44M
2025Q2
20
7.49M
31.98%
+6.93M
2025Q1
20
7.60M
32.43%
+7.41M
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Drugs Made In America Acquisition LLC
4.19M
17.88%
+4.19M
--
Feb 18, 2025
RiverNorth Capital Management LLC
420.50K
1.79%
--
--
Jun 30, 2025
Context Capital Management LLC
250.00K
1.07%
--
--
Jun 30, 2025
Wolverine Asset Management, LLC
130.00K
0.55%
--
--
Jun 30, 2025
Bulldog Investors, LLP
57.30K
0.24%
-72.96K
-56.01%
Jun 30, 2025
Clear Street LLC
45.92K
0.2%
+40.07K
+685.09%
Jun 30, 2025
Robinson Capital Management, LLC
30.00K
0.13%
+20.00K
+200.00%
Jun 30, 2025
Tuttle Capital Management, LLC
20.00K
0.09%
-20.00K
-50.00%
Jun 30, 2025
UBS Financial Services, Inc.
18.39K
0.08%
+107.00
+0.59%
Jun 30, 2025
Citadel Advisors LLC
14.03K
0.06%
-1.73K
-10.96%
Jun 30, 2025
View more
Related ETFs
Updated: Sun, Nov 2
Updated: Sun, Nov 2
Name
Proportion
SPAC and New Issue ETF
2.51%
RiverNorth Enhanced Pre-Merger SPAC ETF
0.49%
CrossingBridge Pre-Merger SPAC ETF
0%
SPAC and New Issue ETF
Proportion2.51%
RiverNorth Enhanced Pre-Merger SPAC ETF
Proportion0.49%
CrossingBridge Pre-Merger SPAC ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
